Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Filters applied: . Clear all
Page 1
Lithium-discontinuation-induced treatment refractoriness revisited.
Kupka R, Regeer E, van Bergen A, Tondo L, Bauer M. Kupka R, et al. Among authors: bauer m. Int J Bipolar Disord. 2024 May 15;12(1):17. doi: 10.1186/s40345-024-00339-6. Int J Bipolar Disord. 2024. PMID: 38750382 Review.
BACKGROUND: Lithium is effective in the long-term treatment of bipolar disorder. Concerns have been raised about non-responsiveness after discontinuation and resuming previously effective lithium prophylaxis. ...Moreover, it may be necessary to continue lithium beyond the …
BACKGROUND: Lithium is effective in the long-term treatment of bipolar disorder. Concerns have been raised about non-responsiveness a …
Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies.
Bauer M, Schöbel CM, Wickenhauser C, Seliger B, Jasinski-Bergner S. Bauer M, et al. Front Immunol. 2024 Apr 26;15:1386993. doi: 10.3389/fimmu.2024.1386993. eCollection 2024. Front Immunol. 2024. PMID: 38736877 Free PMC article. Review.
Despite therapeutic successes have been demonstrated, only a limited number of patients showed long-term benefit from these therapies with tumor entity-related differential response rates were observed. ...
Despite therapeutic successes have been demonstrated, only a limited number of patients showed long-term benefit from these therapies …
Predicting state level suicide fatalities in the united states with realtime data and machine learning.
Patel D, Sumner SA, Bowen D, Zwald M, Yard E, Wang J, Law R, Holland K, Nguyen T, Mower G, Chen Y, Johnson JI, Jespersen M, Mytty E, Lee JM, Bauer M, Caine E, De Choudhury M. Patel D, et al. Among authors: bauer m. Npj Ment Health Res. 2024 Jan 16;3(1):3. doi: 10.1038/s44184-023-00045-8. Npj Ment Health Res. 2024. PMID: 38609512 Free PMC article.
We developed and validated a deep learning based approach to utilize real-time, state-level online (Mental Health America web-based depression screenings; Google and YouTube Search Trends), social media (Twitter), and health administrative data (National Syndromic Surveillance Pr …
We developed and validated a deep learning based approach to utilize real-time, state-level online (Mental Health America web-based depressi …
Clinical Evaluation of the Child with Eosinophilic Esophagitis.
Bauer M, Nguyen N, Liacouras CA. Bauer M, et al. Immunol Allergy Clin North Am. 2024 May;44(2):157-171. doi: 10.1016/j.iac.2023.12.004. Epub 2024 Jan 9. Immunol Allergy Clin North Am. 2024. PMID: 38575215 Review.
Outside of EoE in the context of oral immunotherapy, EoE is typically chronic requiring lifelong therapy. Long-term complications including feeding difficulties, malnutrition, and fibrostenotic disease....
Outside of EoE in the context of oral immunotherapy, EoE is typically chronic requiring lifelong therapy. Long-term complications inc …
Efficacy and safety of zapnometinib in hospitalised adult patients with COVID-19 (RESPIRE): a randomised, double-blind, placebo-controlled, multicentre, proof-of-concept, phase 2 trial.
Rohde G, Stenglein S, Prozesky H, Manudhane G, Sandulescu O, Bauer M, Overend T, Koch W, Neuschwander D, Planz O, Torres A, Witzenrath M. Rohde G, et al. Among authors: bauer m. EClinicalMedicine. 2023 Oct 4;65:102237. doi: 10.1016/j.eclinm.2023.102237. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 38106555 Free PMC article.
Predefined subgroup analyses identified trends for improved CSS in patients with severe disease at baseline (OR 2.57 [0.76-8.88]; p = 0.13) and non-Omicron variants (OR 2.36 [0.85-6.71]; p = 0.10); the p value of the CSS subgroup by Treatment interaction term in the model …
Predefined subgroup analyses identified trends for improved CSS in patients with severe disease at baseline (OR 2.57 [0.76-8.88]; p = 0.13) …
Exploring the genetics of lithium response in bipolar disorders.
Herrera-Rivero M, Adli M, Akiyama K, Akula N, Amare AT, Ardau R, Arias B, Aubry JM, Backlund L, Bellivier F, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Cearns M, Cervantes P, Chen HC, Chillotti C, Cichon S, Clark SR, Colom F, Cruceanu C, Czerski PM, Dalkner N, Degenhardt F, Del Zompo M, DePaulo JR, Etain B, Falkai P, Ferensztajn-Rochowiak E, Forstner AJ, Frank J, Frisén L, Frye MA, Fullerton JM, Gallo C, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hasler R, Hauser J, Heilbronner U, Herms S, Hoffmann P, Hou L, Hsu YH, Jamain S, Jiménez E, Kahn JP, Kassem L, Kato T, Kelsoe J, Kittel-Schneider S, Kuo PH, Kusumi I, König B, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Maj M, Manchia M, Marie-Claire C, Martinsson L, McCarthy MJ, McElroy SL, Millischer V, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Novák T, Nöthen MM, O'Donovan C, Ozaki N, Papiol S, Pfennig A, Pisanu C, Potash JB, Reif A, Reininghaus E, Richard-Lepouriel H, Roberts G, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schubert KO, Schulte EC, Schweizer BW, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Sta… See abstract for full author list ➔ Herrera-Rivero M, et al. Among authors: bauer m. Res Sq [Preprint]. 2023 Dec 2:rs.3.rs-3677630. doi: 10.21203/rs.3.rs-3677630/v1. Res Sq. 2023. PMID: 38077040 Free PMC article. Preprint.
BACKGROUND: Lithium (Li) remains the treatment of choice for bipolar disorders (BP). Its mood-stabilizing effects help reduce the long-term burden of mania, depression and suicide risk in patients with BP. ...BP-I and BP-II) according to the clinical presentation. Moreover …
BACKGROUND: Lithium (Li) remains the treatment of choice for bipolar disorders (BP). Its mood-stabilizing effects help reduce the long-te …
Key questions on the long term renal effects of lithium: a review of pertinent data.
Gitlin M, Bauer M. Gitlin M, et al. Among authors: bauer m. Int J Bipolar Disord. 2023 Nov 16;11(1):35. doi: 10.1186/s40345-023-00316-5. Int J Bipolar Disord. 2023. PMID: 37971552 Free PMC article. Review.
For over half a century, it has been widely known that lithium is the most efficacious maintenance treatment for bipolar disorder. Despite thorough research on the long-term effects of lithium on renal function, a number of important questions relevant to clinical practice …
For over half a century, it has been widely known that lithium is the most efficacious maintenance treatment for bipolar disorder. Despite t …
Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study.
Martini J, Bröckel KL, Leopold K, Berndt C, Sauer C, Maicher B, Juckel G, Krüger-Özgürdal S, Fallgatter AJ, Lambert M, Bechdolf A, Reif A, Matura S, Biere S, Kittel-Schneider S, Stamm T, Bermpohl F, Kircher T, Falkenberg I, Jansen A, Dannlowski U, Correll CU, Fusar-Poli P, Hempel LM, Mikolas P, Ritter P, Bauer M, Pfennig A. Martini J, et al. Among authors: bauer m. Eur Neuropsychopharmacol. 2024 Jan;78:43-53. doi: 10.1016/j.euroneuro.2023.10.001. Epub 2023 Oct 30. Eur Neuropsychopharmacol. 2024. PMID: 37913697 Free article.
Early identification and intervention of individuals with an increased risk for bipolar disorder (BD) may improve the course of illness and prevent long-term consequences. Early-BipoLife, a multicenter, prospective, naturalistic study, examined risk factors of BD beyond fa …
Early identification and intervention of individuals with an increased risk for bipolar disorder (BD) may improve the course of illness and …
University central offices are moving away from doing towards facilitating science communication: A European cross-comparison.
Entradas M, Marcinkowski F, Bauer MW, Pellegrini G. Entradas M, et al. Among authors: bauer mw. PLoS One. 2023 Oct 4;18(10):e0290504. doi: 10.1371/journal.pone.0290504. eCollection 2023. PLoS One. 2023. PMID: 37792688 Free PMC article.
The evidence shows that science communication is a secondary function at central offices of universities, strongly medialised, and points to a supporting role for central structures in facilitating science communication at other levels while moving away from doing it themselves. …
The evidence shows that science communication is a secondary function at central offices of universities, strongly medialised, and points to …
Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years.
Bauer M, Glenn T, Alda M, Grof P, Bauer R, Ebner-Priemer UW, Ehrlich S, Pfennig A, Pilhatsch M, Rasgon N, Whybrow PC. Bauer M, et al. Pharmacopsychiatry. 2023 Sep;56(5):182-187. doi: 10.1055/a-2156-5667. Epub 2023 Sep 7. Pharmacopsychiatry. 2023. PMID: 37678394 Free PMC article.
INTRODUCTION: Longitudinal study is an essential methodology for understanding disease trajectories, treatment effects, symptom changes, and long-term outcomes of affective disorders. Daily self-charting of mood and other illness-related variables is a commonly recommended …
INTRODUCTION: Longitudinal study is an essential methodology for understanding disease trajectories, treatment effects, symptom changes, and …
298 results